Atlas Trials

Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)

Clinical trial NCT01527435 · COMPLETED

Trial details

NCT number
NCT01527435
Sponsor
The Retina Center of St. Louis County, PC
Status
COMPLETED
Study type
OBSERVATIONAL
Exudative Age-Related Macular Degeneration
Start date
2011-12-01
Primary completion
2015-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.